News Archive

Calling All Medical Device Innovators!

We are now accepting proposals for our annual $250K pediatric medical device pitch competition. Up to six innovations will be awarded up to $50,000 each during our 5th Annual Pediatric Surgical Innovation Symposium.

Registration Open – 5th Annual Pediatric Device Innovation Symposium We are pleased to announce that our 5th annual Pediatric Device Innovation Symposium, “Partnering for Breakthroughs in Pediatric Surgery and Care,” is co-locating in San Jose, California in a joint effort with The MedTech Conference powered by AdvaMed – the premiere gathering of medtech professionals in North America.

Join us Sunday, September 24, 2017

Here are some of the event highlights:

Keynotes and panels on topics related to pediatric device innovation Make your Medical Device Pitch for Kids! competition – $250K in funding Invaluable networking opportunities to meet, learn and get inspired by your fellow medtech innovators Special savings when you attend the Symposium and The MedTech Conference

About the Cluster Action Plan TOHealth! brought together diverse participants from Human Health and Sciences ecosystem in the Toronto region to develop Ontario’s first draft Cluster Action Plan under the Partnerships for Jobs and Growth Act. The draft Plan has been approved by the Minister of Economic Development and Growth / Research Innovation and Science and is now subject to a 30 day public consultation. Please download the draft documents using links above and share your comments using the button below. The consultation period ends August 11, 2017.

The Galien Foundation announced today the 2017 Annual Prix Galien USA Awards Nominees.

Worldwide regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research, the Prix Galien recognizes outstanding biomedical and technology product achievement that improves the human condition.

Canaan has put together an $800 million investment fund. The fund positions Canaan to place a fresh round of bets on early-stage biotechs, continuing the strategy that has delivered it paydays as companies including Johnson & Johnson and Teva have snapped up pieces of its portfolio.

The University System of Maryland (USM) has named business innovator David W. Wise, MALD, as director of the Maryland Momentum Fund (MMF), a $25 million fund to support startups formed within the system’s 12 institutions and its incubators. He joined USM on July 24.

Global University Venturing’s last issue before the summer provides an opportunity to look back at the first six months of the year – as the data reveals, it has been a busy period with activity picking up significantly towards the end of the second quarter.

That increased activity, however, appears not to have translated into a boost for the total amount of capital raised compared with the same period last year. Although there were 44 deals in June, they amounted to only $365.3m of transaction value – a drop of nearly $90m from May.

The University of Maryland, Baltimore (UMB) has been selected as one of “The Great Colleges to Work For” by The Chronicle of Higher Education. The results of its national survey, which were released in the magazine’s Academic Workplace supplement that came out July 21, lauded UMB in the categories of collaborative governance, compensation and benefits, and confidence in senior leadership.

Australian biotech, Trimph, has successfully completed a first-in-human trial of its proprietary bone “glue”, TrimphDent, the only bone graft substitute in the world to be applied in liquid form, halving the time of patient recovery, and requiring no specialised preparation or additional surgical expertise.

This breakthrough will allow Trimph to progress towards registering TrimphDent and launching into global markets, which could provide significantly more affordable and accessible oral surgeries to rural and disadvantaged communities across the globe.

An Annapolis firm focused on building medical devices to monitor heart disease has raised $1.5 million to help bring its first product to market.

Vixiar Medical Inc., a spinout of Johns Hopkins, is developing non-invasive devices and systems for monitoring cardiopulmonary diseases. Its seed round included investors from the U.S. Asia and Europe. Local investors include the Abell Foundation and Maryland Technology Development Corp. The company is based on technology licensed from Hopkins and invented by cardiologist Dr. Harry Silber.